In addition to recombination, retroviruses also interact with one another via complementation, which involves the copackaging of viral proteins and/or RNAs. The goals of this project are to gain further insights into virus interactions by studying the mechanisms of virus assembly, RNA packaging, and replication. Using simple retroviruses as a model system, we have examined three aspects of virus assembly. We have dissected a motif that is important for virus assembly and located at the C-terminal region of murine leukemia virus (MLV) capsid (CA). From data generated in our mutational analyses, we hypothesize that the sequences in this motif form an a-helix; maintenance of the helical structure and the phase of the helix are critical to its function. We are performing experiments to further investigate this motif to gain insight into the functional domains of CA in virus assembly. We have performed experiments to determine the domain(s) in Gag that is important for the coassembly of MLV and spleen necrosis virus (SNV) Gag. MLV and SNV are distantly related viruses. Using hybrid viruses, we determined that homologous CA is needed for functional complementation of MLV and SNV Gag. We have also studied the MLV Gag components that are important for early virus replication events. We found that homologous CA and p12 domains are required for efficient virus infection. This study indicated that the mature CA and p12 proteins cooperate during early MLV replication, most likely for the transport of the reverse transcription/preintegration complex. We have also examined the effects of Gag mutations on virion RNA dimer maturation. We examined two Gag mutants: an MLV CA deletion mutation and an HIV-1 PTAP substitution mutant. We found that although most of Gag proteins from these virions were cleaved, virion RNA dimers did not mature. These data suggest that virion RNA dimer maturation requires more than proteolytic cleavage of Gag and is likely to be associated with virion morphological changes. We are now studying functional complementation and coassembly in lentivirus-based systems - namely, HIV-1 and HIV-2. Using a genetic complementation assay and an imaging approach, we have demonstrated that HIV-1 and HIV-2 Gag can coassemble; furthermore, these coassembled viruses can be infectious. To our knowledge, this is the first study of its kind to demonstrate that two lentiviruses can have such interactions. We are currently following several leads in this study. We intend to define the extent of heterologous Gag interaction, and determine the advantage of such mixed particles in virus replication. For example, we intend to determine whether mixed particles can better counter drug treatment and adapt to replication of a different host cell via bypassing of the cellular defense proteins.

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010506-03
Application #
7291851
Study Section
(RML)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2005
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Nikolaitchik, Olga A; Gorelick, Robert J; Leavitt, Maria G et al. (2008) Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication. Virology 375:539-49
Moore, Michael D; Fu, William; Soheilian, Ferri et al. (2008) Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation. Virology 379:152-60
Lee, Sook-Kyung; Boyko, Vitaly; Hu, Wei-Shau (2007) Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins. Virology 360:388-97
Fu, William; Prasad, V V S P; Chen, Jianbo et al. (2007) Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation. Virology 363:210-9
Boyko, Vitaly; Leavitt, Maria; Gorelick, Robert et al. (2006) Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. Mol Cell 23:281-7
Nikolaitchik, Olga; Rhodes, Terence D; Ott, David et al. (2006) Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination. J Virol 80:4691-7
Fu, William; Dang, Que; Nagashima, Kunio et al. (2006) Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol 80:1242-9
Lee, Sook-Kyung; Nagashima, Kunio; Hu, Wei-Shau (2005) Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication. J Virol 79:4159-69
Svarovskaia, Evguenia S; Xu, Hongzhan; Mbisa, Jean L et al. (2004) Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J Biol Chem 279:35822-8
Cheslock, Sara Rasmussen; Poon, Dexter T K; Fu, William et al. (2003) Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination. J Virol 77:7058-66

Showing the most recent 10 out of 11 publications